Sol Gel - New Logo - light.jpg
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
13 mars 2024 07h00 HE | Sol-Gel Technologies Ltd.
Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments
Dermatology Imaging Devices Market
Dermatology Imaging Devices Market Report 2024, with Profiles of FotoFinder, e-con, Longport, Cortex Technology, VisualSonics, Clarius, Koninklijke Philips, Caliber Imaging and Diagnosis & DermLite
12 mars 2024 13h44 HE | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Digital Photographic Imaging, OCT, Dermatoscope, High...
Global Photodynamic Therapy Devices Market
Global Photodynamic Therapy Devices Market Report 2024: Analysis of Products, Applications, End-users and Regional Dynamics to 2034 Featuring Coherent Corp, Biolitec, & Lumibird Medical Among Other Key Players
11 mars 2024 14h11 HE | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Photodynamic Therapy Devices Market Analysis & Forecast to 2024-2034: Market By Product; By Application; By End-user; and By Region" report...
journeylogo (1).jpg
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
11 mars 2024 08h30 HE | Journey Medical Corporation
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that DFD-29 can be safely used for up to 16 weeks with...
alumis logo.png
Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD Annual Meeting
09 mars 2024 12h00 HE | Alumis Inc
Alumis today announced the presentation of positive clinical data from a Phase 2 clinical trial of ESK-001 at AAD 2024.
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
07 mars 2024 16h35 HE | SkinCure Oncology LLC
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy...
STRATA Skin Sciences Logo.jpg
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
07 mars 2024 08h00 HE | STRATA Skin Sciences, Inc.
HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
New Logo.png
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
29 févr. 2024 08h00 HE | Provectus Biopharmaceuticals Inc.
Preclinical Research on Full-Thickness Cutaneous Wound Healing KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB:...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases
27 févr. 2024 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...
Straits Research Pvt Ltd
Global Scar Treatment Market Size is Estimated to Reach USD 21,007 million by 2030, Growing at a CAGR of 9.6%: Straits Research
27 févr. 2024 07h35 HE | Straits Research
New York, United States, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Scarring is a specific aspect of an injury's healing process. The extent and severity of the wound or cut, the site of the damage, age,...